Applied Clinical Trials-10-01-2009

CRO/SPONSOR : The Value of Late-Phase Patient Reported Outcomes Financial Simulation Modeling in Clinical Trials TRIAL DESIGN : A Concise Look at Adaptive LABS : Steps to Optimize Imaging Also in this issue : New FDA Leadership Means Business, EU Works Together to Improve Trial Rules, Interoperability: A Reality or Just a Dream?, Social Media and Health Care

Recent white paper from ACRO emphasizes the need for global trials.

Success and challenges for clinical trials that address these interrelated conditions.

Patient-level feedback from later studies provides a multitude of valuable answers to all stakeholders.

Stiffer enforcement of research standards aims to restore the public's confidence in agency actions.

The ICH GCP guideline continues to age and while members of the Institute of Clinical Research voice the need for its revision, industry debates whether changes are necessary.

Industry news focusing on the people and organizations who work in the clinical trials profession

Is computer system interoperability for clinical data an impending reality or just a dream?

A concise look at this nontraditional approach to clinical studies that explains the how and why of it.

With a PC and some software you can generate realistic projections that save time and money.

The EU struggles to get over its regulatory hurdles in an effort to further R&D success.

How the ability to apply text mining and signal detection algorithms to social media's real-time data provides unheard of value.

Delays and expenses can be spared by crafting plans earlier and more methodically

How changing times require a new approach to partnerships.